|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
01/06/2025 |
$90.75 |
$91.53 |
$90.33 |
$91.23 |
6.78M | 01/07/2025 |
$90.89 |
$91.51 |
$90.51 |
$90.63 |
5.81M | 01/08/2025 |
$90.68 |
$90.68 |
$89.00 |
$89.14 |
8.05M | 01/10/2025 |
$90.19 |
$91.43 |
$88.57 |
$89.88 |
7.87M | 01/13/2025 |
$90.30 |
$90.37 |
$89.02 |
$89.94 |
6.52M |
|
Gilead Sciences is a biopharmaceutical company focused on advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Co. emphasizes the discovery, development, and commercialization of medicines for unmet medical needs. Its marketed products include AmBisome, Atripla, Biktarvy, Descovy (including for PrEP), Epclusa, Genvoya, Harvoni, Sovaldi, Truvada (including for PrEP), Veklury, Vemlidy, Viread, Yescarta, and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Domvanalimab, Zimberelimab, and Seladelpar for treating primary biliary cholangitis (PBC). Co. operates in over 35 countries. | |
|
Gilead Sciences (GILD) has the following price history information. Looking back at GILD historical stock prices for the last five trading days, on January 06, 2025, GILD opened at $90.75, traded as high as $91.53 and as low as $90.33, and closed at $91.23. Trading volume was a total of 6.78M shares. On January 07, 2025, GILD opened at $90.89, traded as high as $91.51 and as low as $90.51, and closed at $90.63. Trading volume was a total of 5.81M shares. On January 08, 2025, GILD opened at $90.68, traded as high as $90.68 and as low as $89.00, and closed at $89.14. Trading volume was a total of 8.05M shares. On January 10, 2025, GILD opened at $90.19, traded as high as $91.43 and as low as $88.57, and closed at $89.88. Trading volume was a total of 7.87M shares. On January 13, 2025, GILD opened at $90.30, traded as high as $90.37 and as low as $89.02, and closed at $89.94. Trading volume was a total of 6.52M shares.
GILD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Gilead Sciences shares, starting with a $10,000 purchase of GILD, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
01/15/2015 |
|
End date: |
01/13/2025 |
|
Start price/share: |
$97.40 |
|
End price/share: |
$89.94 |
|
Starting shares: |
102.67 |
|
Ending shares: |
143.77 |
|
Dividends reinvested/share: |
$24.57 |
|
Total return: |
29.30% |
|
Average Annual Total Return: |
2.60% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$12,927.19 |
|
Years: |
10.00 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
01/15/2015 |
|
End date: |
01/13/2025 |
|
Start price/share: |
$97.40 |
|
End price/share: |
$89.94 |
|
Dividends collected/share: |
$24.57 |
|
Total return: |
17.57% |
|
Average Annual Total Return: |
1.63% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$11,755.43 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
01/06/2025 | $91.23 | 01/07/2025 | $90.63 | 01/08/2025 | $89.14 | 01/10/2025 | $89.88 | 01/13/2025 | $89.94 |
|
|